GCTK - Latest News
GlucoTrack, Inc. (GCTK), operates in Healthcare / Medical - Devices, trades on NASDAQ.
Market capitalization stands near $708,192. Beta to the broader market is 0.68.
The article list below shows the most recent GCTK headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent GCTK Headlines
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
gurufocus.com - Sep 24, 2026
Glucotrack, Inc.
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
businesswire.com - Sep 24, 2026
RUTHERFORD, N. J.
Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket
benzinga.com - Sep 24, 2026
Shares of GlucoTrack Inc (NASDAQ:GCTK) rose sharply in pre-market trading following the announcement that its subsidiary, Lokahi Therapeutics, signed
Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities
businesswire.com - Sep 23, 2026
RUTHERFORD, N. J.
Lōkahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent
gurufocus.com - Sep 18, 2026
LÅkahi Therapeuticsâ¢, a subsidiary of Glucotrack, Inc.
How News Affects GCTK Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track GCTK's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked GCTK news questions
- What is the latest GCTK news headline?
- The most recent GCTK headline (Sep 24, 2026) is "Glucotrack, Inc. Announces Pricing of $3 Million Public Offering". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the GCTK news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What GCTK news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual GCTK options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.